Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionproton channel activity

OTOP2 ATP5MF

1.15e-0427122GO:0015252
GeneOntologyMolecularFunctionproton transmembrane transporter activity

OTOP2 ATP5MF

5.47e-03188122GO:0015078
GeneOntologyBiologicalProcesspositive regulation of ERAD pathway

TMEM259 EIF2AK3

7.12e-0522122GO:1904294
GeneOntologyBiologicalProcesspositive regulation of proteolysis involved in protein catabolic process

AGBL4 TMEM259 EIF2AK3

7.60e-05148123GO:1903052
GeneOntologyBiologicalProcessregulation of ERAD pathway

TMEM259 EIF2AK3

1.25e-0429122GO:1904292
GeneOntologyBiologicalProcesspositive regulation of response to endoplasmic reticulum stress

TMEM259 EIF2AK3

3.03e-0445122GO:1905898
GeneOntologyBiologicalProcessregulation of proteolysis involved in protein catabolic process

AGBL4 TMEM259 EIF2AK3

3.78e-04255123GO:1903050
MousePhenoabnormal pancreatic acinar cell morphology

IFT88 EIF2AK3

2.98e-044192MP:0009146
MousePhenoabnormal pancreatic acinus morphology

IFT88 EIF2AK3

3.28e-044392MP:0009145
MousePhenoabnormal exocrine pancreas morphology

IFT88 EIF2AK3

5.98e-045892MP:0005220
Pubmed

BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.

ZNF609 SEC16A

3.00e-052412233722704
InteractionSMG7 interactions

ZNF609 AGBL4 LENG8 SEC16A

2.76e-05319124int:SMG7
InteractionTSPAN16 interactions

TMEM259 EIF2AK3

7.46e-0522122int:TSPAN16
ComputationalB lymphoma expression clusters.

EIF2AK3 SEC16A

1.12e-038072MODULE_358
ComputationalGenes in the cancer module 97.

EIF2AK3 SEC16A

1.68e-039872MODULE_97
ComputationalGenes in the cancer module 182.

EIF2AK3 SEC16A

1.75e-0310072MODULE_182
ComputationalGenes in the cancer module 262.

EIF2AK3 SEC16A

1.75e-0310072MODULE_261
DrugAmitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A

ZNF609 IFT88 TMEM259

1.15e-041881231865_DN
DrugMeclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A

ZNF609 LZTR1 TMEM259

1.25e-041931231341_UP
DrugThiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A

ZNF609 LZTR1 TMEM259

1.29e-041951237033_UP
DrugBetazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A

ZNF609 LZTR1 TMEM259

1.31e-041961231854_DN
DrugVinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A

ZNF609 IFT88 TMEM259

1.33e-041971233174_DN
DrugFusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A

AMPD3 ZNF609 TMEM259

1.35e-041981232647_UP
DrugAdrenosterone [382-45-6]; Down 200; 13.4uM; HL60; HT_HG-U133A

ZNF609 LZTR1 TMEM259

1.35e-041981233107_DN
DrugAcetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A

AMPD3 ZNF609 LZTR1

1.35e-041981236778_UP
DrugJosamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A

ZNF609 LZTR1 TMEM259

1.35e-041981231534_DN
DrugLeflunomide [75706-12-6]; Down 200; 14.8uM; HL60; HT_HG-U133A

AMPD3 ZNF609 LZTR1

1.37e-041991232539_DN
DrugOleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HT_HG-U133A

AMPD3 ZNF609 TMEM259

1.37e-041991234615_DN
DrugVinpocetine [42971-09-5]; Down 200; 11.4uM; HL60; HG-U133A

AMPD3 LZTR1 EIF2AK3

1.37e-041991231557_DN
Diseaseunipolar depression, bipolar disorder, mental or behavioural disorder

AMPD3 IFT88

2.27e-066122EFO_0000677, EFO_0003761, MONDO_0004985
DiseaseDisproportionate short stature

EXT2 EIF2AK3

4.36e-0477122C0878659
Diseaseaspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement

AMPD3 AGBL4

9.23e-03364122EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Diseasetotal blood protein measurement

ZNF609 SEC16A

1.38e-02449122EFO_0004536
Diseasebody fat percentage

AMPD3 AGBL4

1.61e-02488122EFO_0007800

Protein segments in the cluster

PeptideGeneStartEntry
ILQYPYDNGYYLPYY

EIF2AK3

471

Q9NZJ5
QNPPYSYYLYYMYAN

AMPD3

551

Q01432
YLFAAPYYYGFYNNR

LZTR1

741

Q8N653
PYYYGFYNNRLQAYC

LZTR1

746

Q8N653
YYQWYQQYNYAYPYS

LENG8

86

Q96PV6
QQYNYAYPYSYYYPM

LENG8

91

Q96PV6
FQQGYFYLYPFNIEY

OTOP2

236

Q7RTS6
FGAFQRGYYRYYNKY

ATP5MF

41

P56134
FQYYYESYRYFPCNI

IFT88

606

Q13099
YQFAYCYPYTYTRFQ

AGBL4

161

Q5VU57
RFFYLYHFAFYAYHY

TMEM259

406

Q4ZIN3
LAAYYYYRPLYDAYQ

SEC16A

1156

O15027
GAAFYHKYFNYLYTY

EXT2

596

Q93063
SLYYNQYAYVPPYGY

ZNF609

971

O15014